Zopisign 7.5 mg By HAB Pharma

Zopisign 7.5 mg by HAB Pharma is a medication used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep. The active ingredient in Zopisign is zopiclone, which is a type of medication known as a sedative-hypnotic. Zopiclone works by increasing the activity of a chemical in the brain called gamma-aminobutyric acid (GABA), which helps to reduce brain activity and promote feelings of relaxation and drowsiness.

Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medication side effects, and medical conditions such as sleep apnea or restless leg syndrome. Zopisign 7.5 mg is used to treat insomnia by helping patients fall asleep faster and stay asleep longer. It is typically used for short-term treatment of insomnia, usually no more than two weeks.

Dosage:

• The recommended dosage of Zopisign 7.5 mg by HAB Pharma for adults is one tablet, taken orally, just before bedtime. The tablet should be swallowed whole with water and not crushed, chewed, or broken.
• The recommended duration of treatment with Zopisign is usually 2-4 weeks. In some cases, treatment may need to be extended beyond 4 weeks, but this should only be done under the guidance of a healthcare professional.
• The dosage may need to be adjusted based on factors such as age, medical history, and other medications being taken. To ensure safe and effective use of Zopisign 7.5 mg by HAB Pharma, it’s crucial to adhere to the dosage instructions given by your doctor or pharmacist and avoid exceeding the prescribed dose.
• In elderly patients or those with liver or kidney impairment, the starting dose may be lower, usually 3.75 mg, to reduce the risk of side effects. Your doctor will determine the appropriate dose based on your circumstances.

Instructions:

• It’s important to avoid crushing, chewing, or breaking the Zopisign 7.5 mg tablet and swallow it whole with water to ensure the medication is absorbed properly.
• Avoid drinking alcohol or taking other sedatives while taking Zopisign, as this can increase the risk of side effects.
• Do not take a higher dose than prescribed or continue taking the medication for longer than recommended, as this can increase the risk of dependence or withdrawal symptoms.
• In the event of a missed dose of Zopisign 7.5 mg by HAB Pharma, take the missed dose as soon as you remember. However, do not double the dose to make up for the missed dose.
• Do not drive or operate machinery until you know how the medication affects you, as Zopisign may cause drowsiness or impair your coordination.
• If you experience any side effects while taking Zopisign, such as dizziness, headache, or dry mouth, talk to your doctor or pharmacist.
• If you have trouble sleeping even after taking Zopisign, speak with your doctor or a qualified healthcare provider.
• Store the medication at room temperature, away from moisture and heat, and keep it away from children.

Ingredients:

• Lactose monohydrate
• Microcrystalline cellulose
• Sodium starch glycolate (type A)
• Magnesium stearate
• Colloidal silicon dioxide

Side Effects:

• Drowsiness
• Dry mouth
• Headache
• Nausea
• Dizziness
• Fatigue
• Metallic taste in the mouth
• Difficulty concentrating
• Confusion
• Memory problems
• Allergic reactions
• Changes in mood or behaviour (e.g., aggression, agitation, hallucinations)
• Difficulty breathing